Cleared Special

K093001 - STA-R EVOLUTION EXPERT SERIES HEMOSTASIS SYSTEM AUTOMATED MULTI-PARAMETRIC ANALYZER

K093001 is an FDA 510(k) clearance for STA-R EVOLUTION EXPERT SERIES HEMOSTASI..., manufactured by Diagnostica Stago, Incorporated. The device is a Class 2 Hematology device with product code JPA cleared through the Special 510(k) pathway after a 81-day FDA review.

K093001 · Diagnostica Stago, Incorporated · Hematology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2009
Decision
81d
Days
Class 2
Risk

K093001 is an FDA 510(k) clearance for the STA-R EVOLUTION EXPERT SERIES HEMOSTASIS SYSTEM AUTOMATED MULTI-PARAMETRIC AN.... Classified as System, Multipurpose For In Vitro Coagulation Studies (product code JPA), Class II - Special Controls.

Submitted by Diagnostica Stago, Incorporated (Parisppany, US). The FDA issued a Cleared decision on December 18, 2009 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K093001

510(k) Number K093001 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2009
Decision Date December 18, 2009
Days to Decision 81 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 113d · This submission: 81d
Pathway characteristics
Modification to existing cleared device.

JPA Device Classification - Class 2, Special Controls

Product Code JPA System, Multipurpose For In Vitro Coagulation Studies
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPA System, Multipurpose For In Vitro Coagulation Studies

All 181
Devices cleared under the same product code (JPA) and FDA review panel - the closest regulatory comparables to K093001.
EX-TEM. FIB-TEM, AND AP-TEM FOR ROTEM DELTA THROMBOELASTOMETRY SYSTEM
K101533 · Tem Innovations GmbH · Aug 2011
ROTEM DELTA THROMBOELASTOMETRY SYSTEM
K083842 · Pentapharm GmbH · Mar 2010
STA COMPACT AUTOMATED MULTI-PARAMETRIC ANALYZER
K093167 · Diagnostica Stago, Inc. · Dec 2009
DESTINY MAX COAGULATION ANALYZER
K083896 · Trinity Biotech · Jul 2009
ACL ACUSTAR, HEMOSIL ACUSTAR D-DIMER, HEMOSIL ACUSTAR D-DIMER CONTROLS
K083518 · Instrumentation Laboratory CO · Mar 2009
BERICHROM HEPARIN LMW CALIBRATOR, BERICHROM HEPARIN LMW CONTROL 1, AND BERICHROM HEPARIN LMW CONTROL 2
K083159 · Siemens Healthcare Diagnostics · Jan 2009
K093001 · STA-R EVOLUTION EXPERT SERIES HEMOSTASIS SYSTEM AUTOMATED MULTI-PARAMETRIC ANALYZER
Download PDF FDA Summary Diagnostica Stago, In…